Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code O67.0

Intrapartum hemorrhage with coagulation defect.

Code O67.0 should be used only on the maternal record and never on the newborn record.An additional code from category Z3A, Weeks of gestation, should be used to identify the specific week of the pregnancy, if known. This code excludes antepartum hemorrhage NEC (O46.-), placenta previa (O44.-), premature separation of placenta [abruptio placentae] (O45.-), and postpartum hemorrhage (O72.-).

Medical necessity for the treatment of intrapartum hemorrhage with coagulation defect is established by the life-threatening nature of the condition.Uncontrolled bleeding during labor and delivery can lead to hypovolemic shock, organ failure, and maternal death.Treatment is necessary to stabilize the patient and prevent serious complications.

The physician managing the patient's labor and delivery is responsible for diagnosing and treating intrapartum hemorrhage with coagulation defect. This involves identifying the underlying cause of the coagulopathy, administering appropriate blood products and medications to control bleeding, and monitoring the patient's vital signs and coagulation status.

In simple words: This code describes excessive bleeding during labor and delivery caused by a blood clotting problem.

Intrapartum hemorrhage with coagulation defect. This includes conditions such as afibrinogenemia, disseminated intravascular coagulation (DIC), hyperfibrinolysis, and hypofibrinogenemia complicating the intrapartum period.

Example 1: A 30-year-old woman in the third trimester of pregnancy experiences heavy bleeding during labor. Laboratory tests reveal a decrease in fibrinogen levels, indicating hypofibrinogenemia. The physician administers cryoprecipitate to correct the coagulation defect and manages the hemorrhage., A 25-year-old pregnant woman develops disseminated intravascular coagulation (DIC) during a complicated delivery. This results in widespread activation of the clotting system, leading to both clotting and bleeding.She requires blood product transfusions and intensive care management to stabilize her condition., A 35-year-old woman with a history of von Willebrand disease experiences excessive bleeding after the delivery of her baby.She receives factor VIII concentrate to control the bleeding, which is caused by the deficiency of von Willebrand factor, essential for normal platelet function and blood clotting.

Documentation should include details of the hemorrhage, such as estimated blood loss, vital signs, laboratory results showing coagulation abnormalities (e.g., PT, PTT, fibrinogen, D-dimer), type and amount of blood products administered, and response to treatment. The specific coagulation defect should be documented based on clinical and laboratory findings.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.